A sector-wide selloff splits into two very different stories

Nine stocks tied to the idea that nuclear power will feed the electricity needs of AI data centers have fallen sharply since mid-July — but the group is not falling for one reason. Cameco Corp (CCJ), the Canadian uranium miner that also owns 49% of reactor-builder Westinghouse, and BWX Technologies (BWXT), which builds naval nuclear reactors for the US Navy and is expanding into commercial small modular reactors, both saw their stock-price trend flip from a strong uptrend to a strong downtrend on both the 90-day and 365-day view in early July — even as their order backlogs and realized prices kept growing. Meanwhile pre-revenue reactor developers Oklo (OKLO), NuScale Power (SMR), NANO Nuclear Energy (NNE) and Lightbridge Corp (LTBR) are falling for a more straightforward reason: cash burn is accelerating, share counts are rising, and commercial revenue keeps getting pushed further into the future.

What actually happened

Mid-July brought a one-day drop of 8-9% across Oklo, X-energy, NuScale, NANO Nuclear and Uranium Energy Corp, which commentary at the time attributed to investors rotating out of "the most expensive AI-linked trades" and demanding proof of commercial delivery over speculative growth narratives — not a change in the physical uranium market, which held broadly steady, with spot ending August at $75.13/lb versus a January peak above $101/lb. By July 31, all nine names — Centrus Energy (LEU), the only US-owned commercial uranium enrichment company; Uranium Energy Corp (UEC), the largest US uranium miner by licensed capacity; and Energy Fuels (UUUU), operator of the only conventional uranium mill in the US, among them — were sitting in a downtrend on the chart. The 30-day declines ranged from BWXT's 12.2% to Oklo's 25.8%; Centrus was the lone exception, up 9.1%.

Fundamentals: CONTRADICTS for the established names, CONFIRMS for the startups

Cameco's fundamentals argue against the selloff. Its second-quarter realized uranium price rose 15% year-over-year to $93.13 a pound, and the company holds contracts for average annual deliveries above 28 million pounds over the next five years, while Westinghouse carries a pipeline of 91 AP1000 reactor opportunities and has confidentially filed for an IPO. Yet Cameco's trailing price-to-earnings ratio compressed from 104-117x in May to roughly 80x by late July, and its market value fell from near $50 billion to $36.8 billion — a valuation reset, not a business one. BWXT tells a similar story: backlog reached $8.65 billion, up 77% year-over-year, and JPMorgan initiated coverage at Overweight in late July, projecting double-digit revenue growth through 2028, even as its own P/E fell from the mid-50s to 42x. That divergence — backlogs and prices rising while multiples fall — is a CONTRADICTS reading on the sell-off's premise for these two names; the business hasn't slowed, the stock got expensive and is now less so.

The pre-revenue reactor group tells the opposite story: CONFIRMS. Oklo's trailing free cash flow is negative $154 million, its worst on record, funded by a $1.18 billion share sale that has more than doubled its share count, with no reactor revenue expected before late 2027 and no NRC design approval yet. NuScale's quarterly revenue collapsed to $0.6 million from $13.4 million a year earlier as one-time licensing fees rolled off, and its price-to-sales ratio actually rose, from 121.6x to 161.5x, because revenue fell faster than the stock price — a sign the de-rating is deserved, not excessive. Lightbridge, which develops nuclear fuel rather than reactors, has reported zero revenue every quarter through the first quarter of 2026, funding itself with a $176 million share sale. Centrus sits in between: it holds a $2.3 billion commercial backlog and a $900 million Department of Energy award for enrichment expansion, but the DOE has deferred a decision on Centrus's waiver to keep importing Russian-enriched uranium, an unresolved policy risk. Uranium Energy Corp's production costs rose 25% sequentially to $54.61 a pound as new mines ramped, while its stock still trades at 225 times sales — among the highest multiples in the group. Hyperscaler nuclear deals — Google's 500-megawatt Kairos Power agreement, Amazon's $700 million X-energy investment, Meta's commitments across four reactor developers — are real but dated 2030 to 2035, supporting the case that reactor-name revenue is still years away regardless of how the stocks trade this month.

The one-paragraph technical read

The band break is real and multi-horizon: Cameco and BWXT both flipped from a strong uptrend to a strong downtrend on the 90-day and 365-day charts in early July, not just the 30-day. But the twelve-month picture still separates the two stories — Cameco, BWXT, Uranium Energy and Energy Fuels are each still up 11% to 29% over the past year, while NuScale (-81%), Oklo (-46%), NANO Nuclear (-53%) and Lightbridge (-37%) are down sharply, confirming the reactor micro-caps are dragging the group average, not the fuel-cycle names.

The setup

Where it stands — Fuel-cycle names (Cameco, BWXT) de-rated on multiples despite growing backlogs; pre-revenue reactor names de-rated on deteriorating cash burn and dilution. Would confirm — Cameco's realized price or contracted volume declines in its next quarterly report, extending the de-rating into the business itself. Would invalidate — Oklo or NuScale posts sequential revenue growth without a new share issuance, breaking the dilution-and-burn pattern. Watch next — NuScale's RoPower final investment decision, previously targeted for 2027, and Centrus's pending third Russian-uranium waiver filing. Valuation — Cameco trades near 80x trailing earnings, down from 104-117x in May but still above its multi-year norm; Oklo and NuScale carry no meaningful P/E given losses.